{
"NDC": {
"NDCCode": "42571-166-29",
"PackageDescription": "6 BLISTER PACK in 1 CARTON (42571-166-29) > 10 TABLET, FILM COATED in 1 BLISTER PACK (42571-166-32) ",
"NDC11Code": "42571-0166-29",
"ProductNDC": "42571-166",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Lamivudine, Nevirapine, And Zidovudine",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Lamivudine, Nevirapine, And Zidovudine",
"DosageFormName": "TABLET, FILM COATED",
"RouteName": "ORAL",
"StartMarketingDate": "20180903",
"EndMarketingDate": null,
"MarketingCategoryName": "NDA",
"ApplicationNumber": "NDA205626",
"LabelerName": "Micro Labs Limited",
"SubstanceName": "LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE",
"StrengthNumber": "150; 200; 300",
"StrengthUnit": "mg/1; mg/1; mg/1",
"Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [EXT],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA],Cytochrome P450 3A Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]",
"DEASchedule": null,
"Status": "Deprecated",
"LastUpdate": "2019-12-18",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20191231",
"StartMarketingDatePackage": "20180903",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}